When it comes to muscular diseases, most of us have heard of especially common ones like muscular dystrophy and Lou Gehrig's disease. But one of the rarest muscular disorders is also one of the most ...

Regenxbio said on Thursday that its experimental gene therapy to treat a muscle-wasting disorder met the main ​goal in a late-stage study. The Rockville, ‌Maryland-based company's shares, however, ...

By Padmanabhan Ananthan May 14 (Reuters) - Regenxbio said on Thursday that its experimental gene therapy for a muscle-wasting disorder met the main goal in a late-stage study, but its shares plunged ...

Oct 31 (Reuters) - Sarepta Therapeutics shares (SRPT.O), opens new tab fell nearly 44% on Tuesday, after its gene therapy for a progressive muscle-wasting disorder failed to meet the main goal in a ...

On Tuesday, Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping ...

A groundbreaking study, recently published in Nature Communications, sheds light on a newly identified subtype of muscular dystrophy, revealing an unsuspected role of SNUPN gene in muscle cell ...

Twelve Tufts University lacrosse players were diagnosed with rhabdomyolysis after a voluntary Navy SEAL workout led by a school alum earlier this week. Twelve Tufts University men's lacrosse players ...

We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite being so rare, "improved awareness and diagnostic techniques have led to more frequent diagnoses and better care," says ...